Savara Inc Stock Performance
SVRA Stock | USD 3.36 0.11 3.17% |
The entity has a beta of 1.49, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Savara will likely underperform. At this point, Savara Inc has a negative expected return of -0.28%. Please make sure to validate Savara's potential upside, daily balance of power, as well as the relationship between the Daily Balance Of Power and market facilitation index , to decide if Savara Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Savara Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (3.17) | Five Day Return (0.30) | Year To Date Return (23.11) | Ten Year Return (90.00) | All Time Return (99.90) |
Last Split Factor 1:70 | Dividend Date 2017-04-28 | Last Split Date 2017-04-28 |
1 | Acquisition by Mathers Edward T of 333333 shares of Savara at 3.0 subject to Rule 16b-3 | 09/13/2024 |
2 | Acquisition by Pratt Raymond Dennis of 3500 shares of Savara at 1.5434 subject to Rule 16b-3 | 09/20/2024 |
3 | Savara Announces Expanded Access Program for Molgramostim Inhalation Solution for Patients with Autoimmune Pulmonary Alveolar Proteinosis | 09/27/2024 |
4 | Acquisition by Elam Nevan C of 1758 shares of Savara at 0.82 subject to Rule 16b-3 | 10/17/2024 |
5 | Disposition of 381 shares by Anne Erickson of Savara at 3.57 subject to Rule 16b-3 | 10/21/2024 |
6 | Savara Announces the Rare Lung Disease, Autoimmune Pulmonary Alveolar Proteinosis , is Highlighted on a New Episode of The Balancing Act Airing on Lifetime TV | 10/22/2024 |
7 | Disposition of 49950 shares by Pratt Raymond Dennis of Savara at 3.97 subject to Rule 16b-3 | 11/08/2024 |
8 | Jennison Associates LLCs Strategic Acquisition of Savara Inc Shares | 11/13/2024 |
9 | Acquisition by Ramsay David A of 100000 shares of Savara at 2.876 subject to Rule 16b-3 | 11/18/2024 |
10 | Director David Ramsay Acquires 100,000 Shares of Savara Inc | 11/19/2024 |
11 | Independent Director of Savara Picks Up 4.5 percent More Stock | 11/21/2024 |
12 | Savara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution in Patients with Autoimmune Pulmonary Alveol... | 11/22/2024 |
13 | Estimating The Fair Value Of Savara Inc. | 11/25/2024 |
14 | Vestal Point Capital LP Raises Holdings in Savara Inc | 11/29/2024 |
Begin Period Cash Flow | 52.1 M | |
Free Cash Flow | -51.4 M |
Savara |
Savara Relative Risk vs. Return Landscape
If you would invest 421.00 in Savara Inc on September 2, 2024 and sell it today you would lose (85.00) from holding Savara Inc or give up 20.19% of portfolio value over 90 days. Savara Inc is currently does not generate positive expected returns and assumes 3.6691% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Savara, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Savara Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Savara's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Savara Inc, and traders can use it to determine the average amount a Savara's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0773
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | SVRA |
Estimated Market Risk
3.67 actual daily | 32 68% of assets are more volatile |
Expected Return
-0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Savara is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Savara by adding Savara to a well-diversified portfolio.
Savara Fundamentals Growth
Savara Stock prices reflect investors' perceptions of the future prospects and financial health of Savara, and Savara fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Savara Stock performance.
Return On Equity | -0.48 | ||||
Return On Asset | -0.26 | ||||
Current Valuation | 383.91 M | ||||
Shares Outstanding | 171.62 M | ||||
Price To Earning | (2.46) X | ||||
Price To Book | 2.89 X | ||||
Price To Sales | 131,146 X | ||||
Gross Profit | (28.99 M) | ||||
EBITDA | (59.13 M) | ||||
Net Income | (54.7 M) | ||||
Cash And Equivalents | 142.62 M | ||||
Cash Per Share | 1.25 X | ||||
Total Debt | 26.49 M | ||||
Debt To Equity | 0.20 % | ||||
Current Ratio | 39.23 X | ||||
Book Value Per Share | 1.17 X | ||||
Cash Flow From Operations | (51.06 M) | ||||
Earnings Per Share | (0.43) X | ||||
Market Capitalization | 595.52 M | ||||
Total Asset | 177.56 M | ||||
Retained Earnings | (393.37 M) | ||||
Working Capital | 155.35 M | ||||
About Savara Performance
By analyzing Savara's fundamental ratios, stakeholders can gain valuable insights into Savara's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Savara has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Savara has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.33) | (0.34) | |
Return On Capital Employed | (0.36) | (0.34) | |
Return On Assets | (0.31) | (0.32) | |
Return On Equity | (0.39) | (0.37) |
Things to note about Savara Inc performance evaluation
Checking the ongoing alerts about Savara for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Savara Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Savara Inc generated a negative expected return over the last 90 days | |
Savara Inc has high historical volatility and very poor performance | |
Net Loss for the year was (54.7 M) with loss before overhead, payroll, taxes, and interest of (28.99 M). | |
Savara Inc currently holds about 142.62 M in cash with (51.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
Savara Inc has a frail financial position based on the latest SEC disclosures | |
Over 97.0% of the company shares are owned by institutional investors | |
Latest headline from thelincolnianonline.com: Vestal Point Capital LP Raises Holdings in Savara Inc |
- Analyzing Savara's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Savara's stock is overvalued or undervalued compared to its peers.
- Examining Savara's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Savara's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Savara's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Savara's stock. These opinions can provide insight into Savara's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Savara Stock analysis
When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |